- Home
- RM vs MRVI Comparison
RM vs MRVI Comparison
Compare RM & MRVI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- RM
- MRVI
- Stock Information
- Founded
- RM 1987
- MRVI 2014
- Country
- RM United States
- MRVI United States
- Employees
- RM N/A
- MRVI N/A
- Industry
- RM Finance: Consumer Services
- MRVI Biotechnology: Pharmaceutical Preparations
- Sector
- RM Finance
- MRVI Health Care
- Exchange
- RM Nasdaq
- MRVI Nasdaq
- Market Cap
- RM 414.8M
- MRVI 350.1M
- IPO Year
- RM 2012
- MRVI 2020
- Fundamental
- Price
- RM $43.75
- MRVI $2.42
- Analyst Decision
- RM Hold
- MRVI Hold
- Analyst Count
- RM 2
- MRVI 10
- Target Price
- RM $30.00
- MRVI $5.84
- AVG Volume (30 Days)
- RM 52.0K
- MRVI 1.5M
- Earning Date
- RM 07-30-2025
- MRVI 08-11-2025
- Dividend Yield
- RM 2.74%
- MRVI N/A
- EPS Growth
- RM 35.30
- MRVI N/A
- EPS
- RM 3.47
- MRVI N/A
- Revenue
- RM $591,436,000.00
- MRVI $219,830,000.00
- Revenue This Year
- RM $16.20
- MRVI N/A
- Revenue Next Year
- RM $7.43
- MRVI $7.23
- P/E Ratio
- RM $12.63
- MRVI N/A
- Revenue Growth
- RM 7.19
- MRVI N/A
- 52 Week Low
- RM $25.41
- MRVI $1.67
- 52 Week High
- RM $43.91
- MRVI $9.60
- Technical
- Relative Strength Index (RSI)
- RM 82.31
- MRVI 49.60
- Support Level
- RM $36.88
- MRVI $2.28
- Resistance Level
- RM $42.05
- MRVI $2.47
- Average True Range (ATR)
- RM 1.29
- MRVI 0.14
- MACD
- RM 0.49
- MRVI -0.01
- Stochastic Oscillator
- RM 98.79
- MRVI 27.45
About RM Regional Management Corp.
Regional Management Corp is a diversified consumer finance company that provides installment loan products to customers with limited access to consumer credit from banks, thrifts, credit card companies, and other lenders. It is engaged in consumer finance. The company has the core products which are small and large installment loans. The company also offers optional payment and collateral protection insurance. The company's principal source of revenue is interest and fee income on outstanding loans.
About MRVI Maravai LifeSciences Holdings Inc.
Maravai LifeSciences Holdings Inc is a life sciences company that provides critical products that drive the development of groundbreaking vaccines, drug therapies, cell and gene therapies, and diagnostics. The group's solutions empower research into human diseases and support the entire biopharmaceutical development process from early discovery to commercialization. Its reportable segments are Nucleic acid production and biologics safety testing. It generates a majority of its revenue from Nucleic Acid Production and focuses on the manufacturing and sale of nucleic acid products to support the needs of customers' research, and therapeutic and vaccine programs. In addition, the segment also provides research products for labeling and detecting proteins in cells and tissue samples.